[1] Jones DE. Pathogenesis of primary biliary cirrhosis. Gut, 2007, 56: 1615-1624.
[2] Floreani A, Caroli D, Variola A, et al. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int, 2011, 31: 361-368.
[3] Herold C, Regn S, Ganslmayer M, et al. Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis? Dig Dis Sci, 2002, 47: 2669-2673.
[4] Ludwig J. The pathology of primary biliary cirrhosis and autoimmune cholangitis. Baillieres Best Pract Res Clin Gastro-enterol, 2000, 14: 601-613.
[5] Ilan Y. The assessment of liver function using breath tests. Aliment Pharmacol Ther, 2007, 26: 1293-1302.
[6] Lalazar G, Pappo O, Hershcovici T, et al. A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT. J Viral Hepatol, 2008, 15: 716-728.
[7] Dinesen L, Caspary WF, Chapman RW, et al. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dig Liver Dis, 2008, 40: 743-748.
[8] Braden B, Faust D, Sarrazin U, et al.13C-methacetin breath test fiver function test in patients with chronic hepatitis C virus infection.Aliment Pharmacol Ther, 2005, 21: 179-185.
[9] Afolabi P, Wright M, Wootton SA, et al. Clinical utility of 13C-liver-function breath tests for assessment of hepatic function. Dig Dis Sci, 2013, 58: 33-41.
[10] Vranova J, Hendrichova M, Kolarova H, et al. 13C-methacetin breath test in the evaluation of disease severity in patients with liver cirrhosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2013, 157: 392-400. |
